DailyIQ
|
DailyIQ
|
Last updatedUpdating…

VRDN·Viridian Therapeutics, Inc.

$0.00
+0.00 (+0.00%)
High
$0.00
Open
$0.00
Market Cap
2.16B
52W High
$35.00
Low
$0.00
P. Close
-
P/E
-
52W Low
$10.10
Fwd P/E
-6.91
DailyIQ Est.
-
Inst. Ownership
-
Short Interest
-
Days to Cover
8.9
Technical Score (1D)
33
BEARISH
News Sentiment
48
MIXED
VRDN remains range-bound on the 1D chart at 33, with SELL and declining momentum that refuses to pick a side. Sentiment at 48 is diverging from the chop, so the clean trade is often to wait. $18.29 and $19.81 are the only levels that matter until one breaks with conviction. The longer VRDN sits between $18.29 and $19.81 without resolving, the more energy tends to build for whichever direction eventually wins out. That's not a reason to anticipate the break - it's a reason to have orders ready on both sides so the reaction, whenever it comes, doesn't get missed entirely.
VRDN|Analyst Targets
Bought (1Y)
0 shares
$0
Sold (1Y)
14,212 shares
$348K
Tousignant JenniferChief Legal Officer
Option Exercise10,000 shares2026-08-19
Tousignant JenniferChief Legal Officer
Sell10,000 shares2026-08-19
Tousignant JenniferChief Legal Officer
Option Exercise10,000 shares2026-08-19
Tousignant JenniferChief Legal Officer
Sell4,212 shares2026-08-19
Tripuraneni RadhikaChief Medical Officer
Option Exercise40,000 shares2026-08-14
View full insider trading history →
44/ 100
Bearish
Overall: Bearish
✓Revenue growing year over year
✕Negative net margin
✕Negative operating cash flow
Net Margin
-483.6%
Revenue CAGR
23.8%
Current Ratio
12.65x
Debt / Equity
0.03x
Return on Equity
-47.4%
View full financials →

EPS

EstBeatMiss
$-1.13$-0.90$-0.68$-0.46$-0.24Q3'25Q3'26
QtrEstActual+/−
Q3'26$-1.02 - -
Q3'25$-0.94$-0.34+63.9%

Revenue

EstBeatMiss
$2M$21M$41M$60M$80MQ3'25Q3'26
QtrEstActual+/−
Q3'26$11M - -
Q3'25 - $71M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Sector Rotation

Is money rotating into or out of VRDN's sector?

Viridian Therapeutics, Inc. sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, VRDN ranks 13th of 15 tracked industries, lagging.

Sector rank
#3 of 12
Sector state
Leading
Sector rotation score
82
Industry rank
#13 of 15

Options Market

What is the options market pricing for VRDN?

CallsPuts

For Viridian Therapeutics, Inc.'s nearest expiry (2026-11-20, 33 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 1.92), with at-the-money implied volatility around 124.3%. The options market is pricing roughly a ±31.2% move by that expiry — a range of about $13.09–$24.97.

Put/call ratio (2026-11-20)
1.92
ATM implied volatility
124.3%
Total open interest
73
Expected move by 2026-11-20
±31.2% ($13.09–$24.97)

Corporate Stakes

Which companies own a stake in VRDN?

$1.7Mheld by MRK

Merck & Co., Inc. reports a stake in Viridian Therapeutics, Inc. on SEC Form 13F: 93.4K shares worth $1.7M at the end of Q2 2026.

Holder
MRK
Shares held
93.4K
Value
$1.7M
HolderLast quarterShares% of VRDNValue at filingValue now
Merck & Co., Inc. MRKUnchanged93.4K-$1.7M-

Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it.

News & sentiment

What is the news saying about VRDN?

VRDN fell 15.7% over the month to Oct 16.

Daily close and news tone, Sep 16 to Oct 16
$18$20$22Sep 16Sep 17Sep 18Sep 21Sep 22Sep 23Sep 24Sep 25Sep 28Sep 29Sep 30Oct 1Oct 2Oct 5Oct 6Oct 7Oct 8Oct 9Oct 12Oct 13Oct 14Oct 15Oct 16Sep 16News toneOct 16123
  1. Sep 23 -5.0%
  2. Oct 1 -8.1%
  3. Oct 15 +6.4%
Latest stories naming Viridian Therapeutics

Technical analysis

How strong is VRDN's momentum right now?

On the daily chart VRDN ranks at the 33rd percentile for momentum against the stocks and ETFs DailyIQ tracks, a bearish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling VRDN?

44 of the 77 tracked managers added to VRDN in their latest 13F and 31 trimmed. Together their positions are worth $547.8M.

44adding31trimming2unchanged
Largest holders by stake, latest 13F
  1. 1State Street Corp
    $112.5M positionAdded 31.1% last quarter
  2. 2Vanguard Capital Management LLC
    $84.1M positionAdded 9.8% last quarter
  3. 3Vanguard Portfolio Management LLC
    $50.6M positionAdded 67.7% last quarter
  4. 4Baker Bros. Advisors LP
    $43.8M positionAdded 20.9% last quarter
  5. 5Candriam S.C.A.
    $31.3M positionAdded 139.9% last quarter
  6. 6California State Teachers' Retirement System (CalSTRS)
    $91.4K positionAdded 1.6M shares last quarter
  7. 7Dimensional Fund Advisors LP
    $29.6M positionAdded 204.2% last quarter
  8. 8UBS Group AG
    $26.2M positionAdded 365.2% last quarter
  9. 9Arrowstreet Capital, Limited Partnership
    $20.4M positionAdded 1.1M shares last quarter
  10. 10BNP Paribas Financial Markets
    $18.6M positionAdded 279.9% last quarter
Full holdings history

Discover more

How has VRDN done against its peers?

Over the month to Oct 16, VRDN returned −12.8%. Of the 15 related stocks and ETFs, 13 did better, led by MRNA at +51.2%.

Change since Sep 15Through Oct 16
−20%0%+20%+40%+60%+80%Sep 15Oct 16MRNA +51.2%VRDN −12.8%ROIV −15.2%